2019 Annual Meeting | C91 - Neurology Update III: Headache, Neuro-otology, and Epilepsy

Date Monday 05/06/19

Time 01:00 PM - 03:00 PM EDT Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Adam Quick, MD, Ralph F. Jozefowicz, MD, FAAN

Topic(s) Epilepsy/Clinical Neurophysiology (EEG), Headache, Neuro-ophthalmology/Neuro-otology, General Neurology: Overview

Learning Objectives Participants should understand the indications for newly available headache treatments and how to apply them, discern the common causes of vestibular disfunction and how to differentiate peripheral from central causes of vertigo and imbalance, and recognize and treat the common seizure disorders.

CME Available 2.00 CME credits

Core Competencies Patient Care & Procedural Skills, Medical Knowledge, Practice-based Learning and Improvement

Program Level Intermediate

Program Tracks Advanced Practice Provider

Recommended Audience Fellow, Resident, General Neurologist, Specialist Neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student

Teaching Styles Didactic

Program Materials Program Evaluations

Event Timeline
01:00 PM - 01:40 PM EDT	Speaker	Update in Headache Christopher J. Boes, MD, FAAN
01:40 PM - 02:20 PM EDT	Speaker	Update in Neuro-otology Terry D. Fife, MD, FAAN
02:20 PM - 03:00 PM EDT	Speaker	Update in Epilepsy Gregory K. Bergey, MD, FAAN

Faculty Disclosures
Adam Quick, MD	The institution of Dr. Quick has received research support from NINDS. The institution of Dr. Quick has received research support from NEALS.
Ralph F. Jozefowicz, MD, FAAN	Dr. Jozefowicz has nothing to disclose.
Christopher J. Boes, MD, FAAN	Dr. Boes has a non-compensated relationship as a Review Committee for Neurology member with ACGME that is relevant to AAN interests or activities.
Terry D. Fife, MD, FAAN	Dr. Fife has nothing to disclose.
Gregory K. Bergey, MD, FAAN	Dr. Bergey has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurotherapeutics.

��ɫ��

��ɫ��